These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 30406350)

  • 21. Impact of very early CD4(+) /CD8(+) T cell counts on the occurrence of acute graft-versus-host disease and NK cell counts on outcome after pediatric allogeneic hematopoietic stem cell transplantation.
    Huttunen P; Taskinen M; Siitonen S; Saarinen-Pihkala UM
    Pediatr Blood Cancer; 2015 Mar; 62(3):522-8. PubMed ID: 25417898
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk Factors for Steroid-Refractory Acute Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation from Matched Related or Unrelated Donors.
    Calmettes C; Vigouroux S; Labopin M; Tabrizi R; Turlure P; Lafarge X; Marit G; Pigneux A; Leguay T; Bouabdallah K; Dilhuydy MS; Duclos C; Mohr C; Lascaux A; Dumas PY; Dimicoli-Salazar S; Saint-Lézer A; Milpied N
    Biol Blood Marrow Transplant; 2015 May; 21(5):860-5. PubMed ID: 25617807
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Poor graft function can be durably and safely improved by CD34+-selected stem cell boosts after allogeneic unrelated matched or mismatched hematopoietic cell transplantation.
    Haen SP; Schumm M; Faul C; Kanz L; Bethge WA; Vogel W
    J Cancer Res Clin Oncol; 2015 Dec; 141(12):2241-51. PubMed ID: 26272482
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurologic complications after allogeneic hematopoietic stem cell transplantation in children: analysis of prognostic factors.
    Kang JM; Kim YJ; Kim JY; Cho EJ; Lee JH; Lee MH; Lee SH; Sung KW; Koo HH; Yoo KH
    Biol Blood Marrow Transplant; 2015 Jun; 21(6):1091-8. PubMed ID: 25708217
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of anti-HLA antibodies on allogeneic hematopoietic stem cell transplantation outcomes after reduced-intensity conditioning regimens.
    Detrait M; Dubois V; Sobh M; Morisset S; Tedone N; Labussière H; Gillis L; Barraco F; Cannas G; Ducastelle S; Fatoum J; Thomas X; Chelgoum Y; Nicolini FE; Michallet M
    Exp Hematol; 2012 Oct; 40(10):792-9. PubMed ID: 22705505
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The relationship between circulating natural killer cells after reduced intensity conditioning hematopoietic stem cell transplantation and relapse-free survival and graft-versus-host disease.
    Dunbar EM; Buzzeo MP; Levine JB; Schold JD; Meier-Kriesche HU; Reddy V
    Haematologica; 2008 Dec; 93(12):1852-8. PubMed ID: 18945751
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical characteristics and risk factors of Intracranial hemorrhage in patients following allogeneic hematopoietic stem cell transplantation.
    Zhang XH; Wang QM; Chen H; Chen YH; Han W; Wang FR; Wang JZ; Zhang YY; Mo XD; Chen Y; Wang Y; Chang YJ; Xu LP; Liu KY; Huang XJ
    Ann Hematol; 2016 Oct; 95(10):1637-43. PubMed ID: 27485455
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low Counts of Plasmacytoid Dendritic Cells after Engraftment Are Associated with High Early Mortality after Allogeneic Stem Cell Transplantation.
    Gonçalves MV; Yamamoto M; Kimura EY; Colturato VA; de Souza MP; Mauad M; Ikoma MV; Novis Y; Rocha V; Ginani VC; Wanderley de Oliveira Felix OM; Seber A; Kerbauy FR; Hamerschlak N; Orfao A; Rodrigues CA
    Biol Blood Marrow Transplant; 2015 Jul; 21(7):1223-9. PubMed ID: 25792371
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic factors on graft-versus-host disease-free and relapse-free survival after allogeneic hematopoietic stem cell transplantation for adults with acute leukemia.
    Tan J; Wang Y; Yu SJ; Ma YY; Lei HY; Liu QF
    Leuk Res; 2017 Aug; 59():1-7. PubMed ID: 28527401
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyclosporine in combination with mycophenolate mofetil versus methotrexate for graft versus host disease prevention in myeloablative HLA-identical sibling donor allogeneic hematopoietic cell transplantation.
    Hamilton BK; Rybicki L; Dean R; Majhail NS; Haddad H; Abounader D; Hanna R; Sobecks R; Duong H; Hill BT; Copelan E; Bolwell B; Kalaycio M
    Am J Hematol; 2015 Feb; 90(2):144-8. PubMed ID: 25353395
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Allogeneic hematopoietic stem cell transplantation after reduced intensity conditioning regimen: Outcomes of patients admitted to intensive care unit.
    Mokart D; Granata A; Crocchiolo R; Sannini A; Chow-Chine L; Brun JP; Bisbal M; Faucher M; Faucher C; Blache JL; Castagna L; Fürst S; Blaise D
    J Crit Care; 2015 Oct; 30(5):1107-13. PubMed ID: 26193780
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The intensive care management process in patients with hematopoietic stem cell transplantation and factors affecting their prognosis.
    Boyacı N; Aygencel G; Turkoglu M; Yegin ZA; Acar K; Sucak GT
    Hematology; 2014 Sep; 19(6):338-45. PubMed ID: 24620953
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Survival and graft-versus-host disease in patients receiving peripheral stem cell compared to bone marrow transplantation from HLA-matched related donor: retrospective analysis of 334 consecutive patients.
    Campregher PV; Hamerschlak N; Colturato VA; Mauad MA; de Souza MP; Bouzas LF; Tavares Rde C; Barros JC; Chiattone R; Paz A; Silla L; Vigorito AC; Miranda E; Funke VA; Flowers ME
    Eur J Haematol; 2015 Nov; 95(5):421-5. PubMed ID: 25645430
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of priming with recombinant human granulocyte colony-stimulating factor on conditioning regimen for high-risk acute myeloid leukemia patients undergoing human leukocyte antigen-haploidentical hematopoietic stem cell transplantation: a multicenter randomized controlled study in southwest China.
    Gao L; Wen Q; Chen X; Liu Y; Zhang C; Gao L; Kong P; Zhang Y; Li Y; Liu J; Wang Q; Su Y; Wang C; Wang S; Zeng Y; Sun A; Du X; Zeng D; Liu H; Peng X; Zhang X
    Biol Blood Marrow Transplant; 2014 Dec; 20(12):1932-9. PubMed ID: 25109850
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypoalbuminaemia segregates different prognostic subgroups within the refined standard risk acute graft-versus-host disease score.
    Kharfan-Dabaja MA; Sheets K; Kumar A; Murthy HS; Nishihori T; Tsalatsanis A; Mina A; Mathews J; Ayala E; Chavez J; Perez LE; Betts BC; Anasetti C; Pidala J
    Br J Haematol; 2018 Mar; 180(6):854-862. PubMed ID: 29345306
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Allogeneic transplantation of G-CSF mobilized peripheral blood stem cells from unrelated donors: a retrospective analysis.
    Bornhäuser M; Theuser C; Soucek S; Hölig K; Klingebiel T; Blau W; Fauser A; Runde V; Schwinger W; Rutt C; Ehninger G
    Haematologica; 2000 Aug; 85(8):839-47. PubMed ID: 10942931
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characteristics and outcome of patients presenting to the emergency department after autologous/allogeneic stem cell transplantation.
    Spoerl S; Hendlmeier C; Hapfelmeier A; Wildgruber M; Schmid RM; Peschel C; Saugel B
    Eur J Emerg Med; 2017 Dec; 24(6):435-442. PubMed ID: 27002565
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A single-center analysis of chronic graft-versus-host disease-free, relapse-free survival after alternative donor stem cell transplantation in children with hematological malignancies.
    Inagaki J; Fukano R; Noguchi M; Okamura J
    Int J Hematol; 2017 May; 105(5):676-685. PubMed ID: 28205066
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pre-engraftment syndrome after unrelated donor umbilical cord blood transplantation in patients with hematologic malignancies.
    Wang X; Liu H; Li L; Geng L; Ding K; Liu X; Tong J; Zhu W; Sun Z
    Eur J Haematol; 2012 Jan; 88(1):39-45. PubMed ID: 21933279
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors and prognosis of hepatic acute GvHD after allogeneic hematopoietic cell transplantation.
    Arai Y; Kanda J; Nakasone H; Kondo T; Uchida N; Fukuda T; Ohashi K; Kaida K; Iwato K; Eto T; Kanda Y; Nakamae H; Nagamura-Inoue T; Morishima Y; Hirokawa M; Atsuta Y; Murata M;
    Bone Marrow Transplant; 2016 Jan; 51(1):96-102. PubMed ID: 26367230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.